DCF Calculator for Growth Stocks
TL;DR
Growth stocks demand a multi-stage DCF with explicit deceleration: 20-40% growth in Stage 1, half that by Stage 2, and a long-run terminal at 2-3%. Use a 10-14% WACC, treat SBC as a real cost, and stretch the explicit forecast to 10-15 years so the terminal value does not silently dominate the model. The intrinsic value range matters more than the point estimate — always report the range.
Why growth stocks need a different DCF
Growth stocks — companies expanding revenue at 20% or more per year — are simultaneously the most exciting and the most treacherous candidates for a DCF model. The intrinsic value of a genuine compounder can be vastly underestimated if you anchor too heavily on current earnings. But the same model can justify almost any price if your growth assumptions are unconstrained or your discount rate too low.
The discipline a DCF enforces is its greatest virtue: you are forced to specify how fast the company grows, for how long, at what margins, and at what discount rate. A two-stage model works well here — a high-growth phase followed by a gradual deceleration toward a sustainable terminal growth rate. The gap between Stage 1 and Stage 2 is where most of the analytical judgment lives.
For companies not yet generating positive free cash flow, project forward to when FCF turns positive, using comparable mature companies in the sector to anchor the target margin assumption. The further the FCF-positive milestone is from today, the wider the intrinsic value range — and that range is itself the most important output of the model.
The adjusted DCF formula for growth stocks
A two-stage growth-stock DCF uses the same skeleton as any other DCF, but the structure and inputs are very different:
Intrinsic Value = sum(t=1 to 10) [ FCF_t / (1 + WACC)^t ] + TV / (1 + WACC)^10
Where TV = FCF_10 x (1 + g_terminal) / (WACC - g_terminal)
Growth-specific adjustments:
- Revenue-first projection. For pre-FCF names, forecast revenue out 10-15 years, then apply a target steady-state FCF margin to derive future FCF.
- Explicit deceleration. Stage 1 growth in years 1-5 (e.g., 30%) steps down to Stage 2 growth in years 6-10 (e.g., 15%) before terminal growth of 2-3%.
- Higher WACC. 10-14% is the working range; 14-20% for pre-profit or very-early-stage names.
- SBC-adjusted FCF. Subtract SBC from reported FCF or grow share count to reflect dilution.
- Longer explicit window. 10-15 years rather than the standard 5-10, so the terminal value sits below 65-70% of total intrinsic value.
Worked example: Tesla (TSLA)
Tesla is the canonical contested growth-stock DCF: aggressive bulls model the company as a multi-arm energy and robotaxi platform; conservatives treat it as an automaker that should trade closer to industry multiples. The DCF discipline forces both views to show their work. The illustrative numbers below are anchors, not forecasts.
Starting inputs (illustrative). Assume TSLA generates approximately $4.5B of free cash flow on a trailing basis with about 3.2B shares outstanding. The company has a beta above the market average, justifying a WACC of 11-13%. Analyst consensus expects high-teens to low-20s revenue growth over the next three years, with the long-term trajectory dependent on energy and autonomous mobility execution.
Stage 1 (years 1-5): high growth. Model 22% FCF growth in year 1, tapering to roughly 15% by year 5 as the auto business matures and energy storage scales. This produces year-5 FCF near $10.5B under the illustrative path.
Stage 2 (years 6-10): deceleration. Step the growth rate down to 10% in year 6, then linearly to 5% by year 10. Year-10 FCF lands near $17B in this scenario.
Terminal value. Apply a 3.0% terminal growth rate to reflect a durable platform position. Terminal value = $17B x 1.03 / (0.12 - 0.03) = approximately $195B. Discount this back ten years at 12% WACC to roughly $63B in present-value terms.
Sum of present values. Discount each of the ten Stage-1 and Stage-2 FCF figures back at 12% WACC and add them to the terminal present value. The example yields a total enterprise value near $135-150B. Subtract net debt (TSLA has net cash) and divide by share count to obtain intrinsic value per share. Note how heavily the result depends on the deceleration assumption — a slower deceleration adds tens of billions in value.
Sensitivity is the entire game. Re-run the model with WACC at 10%, 12%, and 14%, and with terminal growth at 2%, 2.5%, and 3%. The intrinsic value spread is often 80-120% wide. That is not a flaw — it is an accurate representation of the uncertainty embedded in any growth-stock forecast.
Run the calculation
The calculator below pre-fills financials from any ticker. For growth stocks, set the WACC to 10-14%, choose an aggressive Stage 1 growth rate, model an honest deceleration, and keep terminal growth at 2-3%. Watch how every input moves the intrinsic value — that sensitivity is the model telling you which assumptions actually matter.